However, recent data indicate that specific clones of B cells (e.g., IgM-producing B1 B cells) and certain complement subunits (e.g., C4) also play neuroprotective roles and could be used in the future therapy of many types of neurologic disorders, including TBI, MS, AD, and epilepsy. This evidence concerns the gene CD40LG and Alzheimer disease.